COMPUMED, INC. RELEASES NEW VERSION OF OSTEOGRAMŽ SOFTWARE WITH ENHANCED PACS/DICOM CAPABILITIES
PACS SYSTEM VENDOR AMS BEGINS SHIPPING THE SOFTWARE
LOS ANGELES, Aug 02, 2007. CompuMed, Inc. (CMPD.OB)-- a medical informatics company serving the healthcare community with diagnostic software solutions -- announced today that it has expanded its support of PACS/DICOM in its OsteoGram(R) software.
The picture archiving and communication systems (PACS) is standard for the interoperability and storage of medical imaging and typically supports the Digital Imaging and Communications in Medicine (DICOM) image format.
Now shipping, OsteoGram 1.36 includes the capability to send images to PACS systems directly from the OsteoGram report module, as well as the ability to query and retrieve images from PACS directly. This enhances support for PACS/DICOM implementations and makes sending DICOM reports faster and easier.
Maurizio Vecchione, CompuMed's CEO, said," This software enhancement is important because it paves the way for integration between our software and other devices that offer bone density testing in conjunction with additional screenings." He added, "We believe that the market is rapidly evolving towards linking bone health testing with procedures such as mammography and other routine procedures." Mr. Vecchione added that CompuMed's vision is to integrate OsteoGram more tightly with other devices so that bone density screening can be performed as part of integrated workflow. "This software release takes us a step closer to that reality," he said.
CompuMed also announced that American Medical Sales Inc. (AMS), a PACS/DICOM system integrator, is now offering and installing OsteoGram throughout its customer base. AMS has more than 50 years of experience and has spent thousands of hours working with radiologists and other medical imaging professionals designing better viewing stations to increase productivity and improve readings.
About CompuMed:
CompuMed, Inc. (CMPD.OB) develops and markets products and services that use advanced imaging and medical informatics to provide analysis and remote monitoring in connection with cardiovascular and musculoskeletal diseases. CompuMed has specialized expertise and intellectual properties in telemonitoring imaging and analysis designed to improve healthcare provider workflow and patient care, while reducing costs. CompuMed's core products, the OsteoGram(R) and CardioGram(TM), are cleared by the FDA and reimbursable by Medicare. The OsteoGram is a non-invasive and simple diagnostic system that has been proven by many clinical studies to be an effective and accurate bone density measurement in connection with screening for osteoporosis and assessing hip fracture risk. The OsteoGram has significant cost advantages over other technologies in the marketplace. The CardioGram system is one of the first telecommunication networks designed to remotely interpret electrocardiograms and is used by private practice, as well as government and corporate healthcare providers nationwide. The CardioGram delivers online electrocardiogram interpretations within minutes of receipt and has the additional capability of automatically providing an over-read (i.e., follow-up review) by a cardiologist. CompuMed is headquartered in Los Angeles and distributes its products worldwide both directly and through OEM partners. Visit CompuMed at www.compumed.net.
About AMS:
For over 50 years AMS has specialized in medical image display and storage. Today this means digital imaging, PACS, workstations, archives, digitizers, web viewing, etc. Those seeking cost-effective, no-nonsense answers to this new radiology reality use AMS Catella PACS systems and appliances. AMS is also grounded in the "film" radiology world. AMS is one of the largest sources for x-ray illuminators, motorized viewers, darkroom products, safelights, cassettes, film and more. AMS also provides specialty x-ray equipment through its American Dental division. Visit AMS at www.digitalams.com.
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning CompuMed's plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements that are not statements of historical fact. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, ability to raise capital, the availability of appropriate acquisition candidates and/or business partnerships, economic conditions, the impact of competition and pricing, capacity and supply constraints or difficulties, government regulation and other risks identified in the Company's filings with the Securities and Exchange Commission. All such forward-looking statements are expressly qualified by these cautionary statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof, except as required by law.
CONTACT: Susan Tellem - Tellem Worldwide, +1 (310) 479-6111 x.16.